• List Price: $179.95
  • Save: $33.51 (19%)
Only 1 left in stock (more on the way).
Ships from and sold by Amazon.com.
Gift-wrap available.
+ $3.99 shipping
Used: Good | Details
Sold by -Daily Deals-
Condition: Used: Good
Comment: This Book is in Good Condition. Used Copy With Light Amount of Wear. 100% Guaranteed.
Sell yours for a Gift Card
We'll buy it for $7.25
Learn More
Trade in now
Have one to sell? Sell on Amazon
Flip to back Flip to front
Listen Playing... Paused   You're listening to a sample of the Audible audio edition.
Learn more
See all 2 images

Beyond Apoptosis: Cellular Outcomes of Cancer Therapy Hardcover – September 19, 2008

See all formats and editions Hide other formats and editions
Amazon Price New from Used from
"Please retry"
$81.90 $41.90


Holiday Deals in Books
Holiday Deals in Books
Find deals for every reader in the Holiday Deals in Books store, featuring savings of up to 50% on cookbooks, children's books, literature & fiction, and more.

Product Details

Editorial Reviews

About the Author

IGOR B. RONINSON is Director of the Cancer Center, Ordway Research Institute, and Adjunct Professor at Albany Medical College, Rensselaer Polytechnic Institute, and State University of New York at Albany, Albany, NY, USA. Dr. Roninson received his Ph.D. in Biochemistry from the Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. He is a member of the American Association for Cancer Research and Associate Editor of several journals in the field of cancer. Dr. Roninson is an accomplished journal contributor, invited lecturer, and inventor. He has been honored with several awards, including the AACR Award for Meritorious Achievement in Cancer Research. His major fields of research are mechanisms of cancer drug resistance and sensitivity, cell senescence in cancer and aging, and drug target identification through functional genomics.

J. MARTIN BROWN is Professor of Radiation and Cancer Biology, Stanford University, Palo Alto, California, USA. Dr. Brown obtained his Ph.D. in Radiation and Cancer Biology from Oxford University, Oxford, UK. He is active member of the American Association for Cancer Research and the Association for Radiation Research, and he serves as chair of the External Advisory Committee of Radiation Leukemogenesis NSCOR. Dr. Brown has received the Henry S. Kaplan Distinguished Scientist and other influential awards, such as the Radiation Research Society Failla Award. His major fields of interest and research are molecular determinants of tumor response to therapy, tumor hypoxia, hypoxic cytotoxins, gene therapy, DNA repair, and genomic instability.

DALE E. BREDESEN is Director and CEO, Buck Institute for Age Research, Novato, and Adjunct Professor, The University of California, San Francisco, California, USA. Dr. Bredesen received his M.D. from Duke University Medical Center, Durham, North Carolina, USA. He has been the recipient of many awards, including the Arthur Cherkin Award for Research in Neurodegenerative Disease, and the Lou and Eleanor Gehrig Lectureship award for the most outstanding work on amyotrophic lateral sclerosis (ALS). Dr. Bredesen is a member of the Society for Neuroscience and the American Society for Biochemistry and Molecular Biology. His research at the Buck Institute, the only independent institute in the US devoted to researching aging and age-related disease, has helped to treat aging individuals affected by neurodegenerative diseases and cancer.

Important Information

Example Ingredients

Example Directions

More About the Author

Discover books, learn about writers, read author blogs, and more.

Customer Reviews

There are no customer reviews yet.
5 star
4 star
3 star
2 star
1 star
Share your thoughts with other customers